Immunic AG | WebDisclosure

Switch to English

11058	Sociétés
242536	Mots-clés
170780	Articles
130530	Communiqués

Accueil
Sociétés
Immunic AG

COMMUNIQUÉ DE PRESSE

publié le 28/05/2026 à 12:30, il y a 3 mois 26 jours

Immunic to Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the CMSC Annual Meeting 2026, Reinforcing Its Potential in Progressive Multiple Sclerosis
Immunic to present additional Phase 2 CALLIPER Trial data for Vidofludimus Calcium at CMSC Annual Meeting 2026, reinforcing its potential in progressive multiple sclerosis

Immunic Vidofludimus Calcium Phase 2 Progressive Multiple Sclerosis CALLIPER Trial
BRÈVE

publiée le 27/05/2026 à 12:35, il y a 3 mois 27 jours

Immunic nomme Erik Lundgren nouveau PDG

Sclérose En Plaques Immunitaire Essais De Phase 3 Erik Lundgren Calcium De Vidofludimus
BRÈVE

publiée le 27/05/2026 à 12:35, il y a 3 mois 27 jours

Immunic Appoints Erik Lundgren as New CEO

Multiple Sclerosis Immunic Vidofludimus Calcium Phase 3 Trials Erik Lundgren
COMMUNIQUÉ DE PRESSE

publié le 27/05/2026 à 12:30, il y a 3 mois 27 jours

Immunic Appoints Distinguished Biopharmaceutical Executive Erik Lundgren as Chief Executive Officer
Immunic appoints Erik Lundgren as CEO to lead transition to commercial-stage MS company. Lundgren's extensive biopharmaceutical experience brings strategic and operational expertise to Immunic

Biopharmaceutical CEO Multiple Sclerosis Immunic Erik Lundgren
BRÈVE

publiée le 19/05/2026 à 12:35, il y a 4 mois 4 jours

Immunic nomme Michael W. Bonney président du conseil d'administration

Sclérose En Plaques Vidofludimus Calcium Leadership Biopharmaceutique Michael W. Bonney Conseil D'immunisation
BRÈVE

publiée le 19/05/2026 à 12:35, il y a 4 mois 4 jours

Immunic Appoints Michael W. Bonney as Chair of the Board

Multiple Sclerosis Vidofludimus Calcium Biopharmaceutical Leadership Michael W. Bonney Immunic Board
COMMUNIQUÉ DE PRESSE

publié le 19/05/2026 à 12:30, il y a 4 mois 4 jours

Immunic Appoints Seasoned Biopharmaceutical Executive Michael W. Bonney as Chair of the Board of Directors
Immunic appoints Michael W. Bonney as Board Chair, bringing over 30 years of biopharmaceutical experience. Bonney led successful commercialization of Avonex® for MS. Exciting plans for future therapies

Biopharmaceutical Immunic Board Chair Michael W. Bonney Avonex
BRÈVE

publiée le 13/05/2026 à 12:35, il y a 4 mois 10 jours

Immunic, Inc. publie des mises à jour financières et stratégiques clés pour le premier trimestre 2026

Immunic, Inc. Sclérose En Plaques Vidofludimus Calcium Financement Des Biotechnologies Résultats Du T1 2026
BRÈVE

publiée le 13/05/2026 à 12:35, il y a 4 mois 10 jours

Immunic, Inc. Reports Key Financial and Strategic Updates for Q1 2026

Immunic, Inc. Multiple Sclerosis Vidofludimus Calcium Q1 2026 Results Biotechnology Funding
COMMUNIQUÉ DE PRESSE

publié le 13/05/2026 à 12:30, il y a 4 mois 10 jours

Immunic, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update
Immunic, Inc. announces First Quarter 2026 Financial Results and corporate updates including appointment of Michael A. Panzara, M.D., M.P.H. as Chief Medical Officer and progress in ENSURE Trials for MS treatment

Financial Results Corporate Update Immunic Inc. First Quarter 2026 Michael A. Panzara

Les Echos

Publié le 23/09/2026 à 08:00, il y a 5 heures 2 minutes

Résultats semestriels 2026 - ANR par action : 101,90 €, en progression de 8,18 % - Capitaux propres consolidés : 774,5 M€
Publié le 22/09/2026 à 18:10, il y a 18 heures 52 minutes

Financial statements - 30 june 2026
Publié le 22/09/2026 à 18:00, il y a 19 heures 2 minutes

Consolidated results for the first half of 2026 EBITDA : 60,5 M€
Publié le 22/09/2026 à 18:00, il y a 19 heures 2 minutes

Résultats consolidés du premier semestre 2026 EBITDA : 60,5 M€
Publié le 22/09/2026 à 17:45, il y a 19 heures 17 minutes

Imerys-09-2026-information-share-capital-and-voting-rights-as-of-31-August-2026

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 23/09/2026 à 12:40, il y a 22 minutes

SouthGobi Announces Update on Upcoming Special Meeting of Shareholders and Postponement of The Record Date
Publié le 23/09/2026 à 09:05, il y a 3 heures 57 minutes

Algo Grande Copper Confirms 68.43 Metres of Copper-Silver-Gold Mineralization Across Two Zones in Hole AG-CG-PH2-002, Including a New Zone of 38.20 Metres at 1.0% CuEq
Publié le 23/09/2026 à 08:00, il y a 5 heures 2 minutes

Caledonia Mining Corporation Plc: Notification of Relevant Change to Significant Shareholder
Publié le 23/09/2026 à 07:30, il y a 5 heures 32 minutes

Tocvan Expands El Mezquite; Drilling Returns 106.8 m of 0.5 g/t Au
Publié le 23/09/2026 à 04:45, il y a 8 heures 17 minutes

SAINT BELLA Marks First Anniversary at Waldorf Astoria Monarch Beach

Voir tout ACCESSWIRE

EQS Group

Publié le 23/09/2026 à 12:25, il y a 37 minutes

SANY Renewable Energy Reports Over 300% Overseas Revenue Growth at WindEnergy Hamburg 2026
Publié le 23/09/2026 à 12:05, il y a 57 minutes

Constellation Cold Logistics ("Constellation") announced today the appointment of Abhy Maharaj as Chief Executive Officer
Publié le 23/09/2026 à 12:00, il y a 1 heure 2 minutes

Shanghai Electric Presents Three Energy Transition Solutions at Enlit Asia 2026
Publié le 23/09/2026 à 11:46, il y a 1 heure 16 minutes

Turkiye Garanti Bankasi A.S.: Intermediary Institution Warrants Issuance Application
Publié le 23/09/2026 à 11:44, il y a 1 heure 18 minutes

Seahawk Investments Expands Alternative Investment Platform with Launch of Maritime Private Credit Fund